News
April 5, 2018

First-in-human Dosing of GNS561 in Liver Cancer Patients

First-in-human Dosing of GNS561 in Patients with Advanced Liver Cancer at the Jules Bordet Institute,…
Read More
News
December 6, 2017

GNS561 Gets US FDA IND Approval in Liver Cancer

Genoscience Pharma Receives FDA Approval for Phase Ib/IIa Study of GNS561 in Liver Cancer  …
Read More
News
February 24, 2016

Four New Members in Our Directory Board

Four New Members in Our Directory Board   Marseille, France, February 24, 2016 – Genoscience Pharma…
Read More
News
February 6, 2012

BL-8030 worldwide License Agreement with BioLineRx

RFS Pharma and Genoscience Pharma enter Worldwide License Agreement with BioLineRx to develop and commercialize Hepatitis…
Read More
News
January 24, 2012

BL-8020 exclusive License Agreement with BioLineRx

BioLineRx signs exclusive License Agreement for BL-8020, an oral Hepatitis C treatment   Jerusalem, Israel,…
Read More
News
June 19, 2007

Joint Venture Agreement with RFS Pharma

RFS Pharma and Genoscience Pharma Sign Joint Venture Agreement to Discover and Develop Protease Inhibitors…
Read More